Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conferences

MENLO PARK, Calif., Sept. 03, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences: Wells Fargo Virtual Healthcare Conference on September 10, 2021, Fireside Chat at 12:40 pm Eastern Time (9:40 am Pacific Time) Morgan Stanley 19th Annual Global Healthcare... Read more

Xylem 2021 Investor Day to be Held Virtually

RYE BROOK, N.Y.–(BUSINESS WIRE)–Aug. 26, 2021– Xylem, Inc. (NYSE: XYL), a leading global water technology company, today announced the format of its 2021 Investor Day will be virtual, in response to emerging public health guidance in relation to COVID-19. The event will be held as previously announced on September 30 beginning at 8:30 am, U.S.... Read more

Young Scientist Develops Neurodegenerative Disease Screening

We already introduced Neha Mani, the winner of the Regeneron International Science and Engineering Fair 2021 in Applied Microbiology. Ron Nachum was awarded in the category of Disease Detection and Diagnosis and therefore also received a ZEISS Primostar 3 microscope donation. Ron is a senior at Thomas Jefferson High School for Science and Technology (Virginia, USA).... Read more

MKS Instruments Declares Quarterly Cash Dividend

ANDOVER, Mass., July 27, 2021 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.22 per share, payable on Read more

microRNAs as Possible Targets for Obesity Treatment

Researchers use widefield microscopy to image adipose and brain tissue as part of their work to find new ways to treat obesity. Obesity refers to the excessive amount of body fat, often as a result from eating more calories (energy) than are used. This can be a serious medical issue with increased risk of health... Read more

Japan becomes first country to approve Ronapreve (casirivimab and imdevimab) for the treatment of mild to moderate COVID-19

Full approval is based on a global phase III trial which found casirivimab and imdevimab reduced hospitalisation or death by 70% in high-risk non-hospitalised patients Basel, 20 July 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Ronapreve™(casirivimab and imdevimab), for the treatment... Read more

Xylem Innovation Cuts Treatment Clarification Costs, Delivers 80% Reduction Of Solids With Reduced Maintenance

Flow Capacity Increases Up To 100% With Leopold TexlerTM Lamella Clarifier Breakthrough Design Uses Inclined Hydrophobic Geotextile Lamella Sheets To Increase Water Production RYE BROOK, N.Y.–(BUSINESS WIRE)–Jul. 19, 2021– Global water technology company, Xylem (NYSE:XYL), has today unveiled a breakthrough solution to support the efficient removal of solids in water treatment applications. Xylem’s new Leopold... Read more